Literature DB >> 24913373

Breast cancer: RARRES3-suppressing metastases to the lung in breast cancer.

Alessia Errico.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24913373     DOI： 10.1038/nrclinonc.2014.103

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation.

Authors:  Mònica Morales; Enrique J Arenas; Jelena Urosevic; Marc Guiu; Esther Fernández; Evarist Planet; Robert Bryn Fenwick; Sonia Fernández-Ruiz; Xavier Salvatella; David Reverter; Arkaitz Carracedo; Joan Massagué; Roger R Gomis
Journal:  EMBO Mol Med       Date:  2014-07       Impact factor: 12.137
  1 in total
  5 in total

1.  The antitumor effect of TIG3 in liver cancer cells is involved in ERK1/2 inhibition.

Authors:  Yan Xu; Ting Chen; Degui Liao; Xiaoqin Wu; Yun Zhong; Shiming Liu; Hui Yang; Yuqiang Nie
Journal:  Tumour Biol       Date:  2016-03-08

2.  RARRES3 suppressed metastasis through suppression of MTDH to regulate epithelial-mesenchymal transition in colorectal cancer.

Authors:  Zhengting Wang; Liying Wang; Jiajia Hu; Rong Fan; Jie Zhou; Lei Wang; Jie Zhong
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

3.  Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.

Authors:  Floriana Centritto; Gabriela Paroni; Marco Bolis; Silvio Ken Garattini; Mami Kurosaki; Maria Monica Barzago; Adriana Zanetti; James Neil Fisher; Mark Francis Scott; Linda Pattini; Monica Lupi; Paolo Ubezio; Francesca Piccotti; Alberto Zambelli; Paola Rizzo; Maurizio Gianni'; Maddalena Fratelli; Mineko Terao; Enrico Garattini
Journal:  EMBO Mol Med       Date:  2015-07       Impact factor: 12.137

4.  Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating RARRES3 gene expression via sponging miR-12.

Authors:  Xihua Wei; Xuelian Gu; Min Ma; Chunxiang Lou
Journal:  Onco Targets Ther       Date:  2019-08-12       Impact factor: 4.147

5.  An immune-related prognostic signature for predicting breast cancer recurrence.

Authors:  Zelin Tian; Jianing Tang; Xing Liao; Qian Yang; Yumin Wu; Gaosong Wu
Journal:  Cancer Med       Date:  2020-08-25       Impact factor: 4.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.